SCHEMBL17755753

SCHEMBL17755753

C[C@@H](CC(=O)Nc1ccccc1)c1noc2c1CCCC2

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 7/20 0.48
▸ LMNA P02545 5/20 0.48
▸ MAPK1 P28482 1/20 0.48
▸ NPC1 O15118 11/20 0.46
▸ RAB9A P51151 11/20 0.46
▸ SMN1; SMN2 Q16637 9/20 0.46
▸ RECQL P46063 3/20 0.46
▸ MAPT P10636 3/20 0.46
▸ KDM4E B2RXH2 2/20 0.46
▸ HSD17B10 Q99714 2/20 0.46
▸ POLB P06746 2/20 0.46
▸ TDP1 Q9NUW8 2/20 0.46
▸ ESR1 P03372 1/20 0.46
▸ NR4A1 P22736 1/20 0.46
▸ ESR2 Q92731 1/20 0.46
▸ TP53 P04637 4/20 0.46
▸ NPSR1 Q6W5P4 2/20 0.46
▸ KMT2A Q03164 2/20 0.46
▸ NFKB1 P19838 1/20 0.46
▸ NFKB2 Q00653 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17755760 1.00 ALDH1A1 (0.48) ALDH1A1LMNAMAPK1NPC1RAB9A
SCHEMBL17755774 0.88 NPC1 (0.47) ALDH1A1LMNAMAPK1NPC1RAB9A
SCHEMBL17755770 0.78 HPGD (0.49) ALDH1A1LMNANPC1RAB9ASMN1; SMN2
SCHEMBL17755766 0.78 HPGD (0.49) ALDH1A1LMNANPC1RAB9ASMN1; SMN2
SCHEMBL17755720 0.76 NPC1 (0.48) ALDH1A1LMNANPC1RAB9ASMN1; SMN2
SCHEMBL17755758 0.75 ALDH1A1 (0.47) ALDH1A1LMNAMAPK1NPC1RAB9A
SCHEMBL17755755 0.75 ALDH1A1 (0.47) ALDH1A1LMNAMAPK1NPC1RAB9A
SCHEMBL17755785 0.75 HPGD (0.41) ALDH1A1LMNANPC1RAB9ASMN1; SMN2
SCHEMBL17755781 0.75 HPGD (0.41) ALDH1A1LMNANPC1RAB9ASMN1; SMN2
SCHEMBL17755783 0.75 LMNA (0.46) ALDH1A1LMNAMAPK1SMN1; SMN2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160137639-A1 TRIAZOLE-ISOXAZOLE COMPOUND AND MEDICAL USE THEREOF JAPAN TOBACCO INC. (JP) 2016-05-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160137639-A1 TRIAZOLE-ISOXAZOLE COMPOUND AND MEDICAL USE THEREOF CYP3A7, CYP2C19, CYP3A5 ALDH1A1 560/4885LMNA 4195/4885MAPK1 1901/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback